| Personalized DC Vaccine for Postoperative Cancer (NCT04147078) | Sichuan University | 2019-06-01 |
| Comparing Two Treatments That Both Target Smoking Cessation and Weight Loss at the Same Time. (NCT04130698) | Rhode Island College | 2019-06-01 |
| Aalgesic Efficacy of Erector -Spinae Technique With Levobupvicaine in Patients Undergoing Upper Abdominal Cancer Surgery (NCT04315454) | South Egypt Cancer Institute | 2019-06-01 |
| Use of Ziv Aflibercept in Different Retinal Diseases (NCT04290195) | Amin El Sayed Nawar | 2019-06-01 |
| A Study to Investigate Differences in the Extent and Rate of Absorption of Doxylamine/Pyridoxine From 2 Different Products Under Fasting Conditions (NCT03905564) | Grünenthal GmbH | 2019-06-01 |
| Pharmacokinetics and Safety of DWP14012 Tablet A and Tablet B in Healthy Volunteers (NCT04003441) | Daewoong Pharmaceutical Co. LTD. | 2019-06-01 |
| Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatments and Combinations in Patients With Urothelial Carcinoma (MORPHEUS-UC) (NCT03869190) | Hoffmann-La Roche | 2019-06-01 |
| Trabectedin, Doxorubicin and Olaratumab in Patients With Metastatic or Recurrent Leiomyosarcoma (NCT03437070) | University of Miami | 2019-06-01 |
| Pharmacodynamics, Safety, Tolerability and Pharmacokinetics of CDX-6114 in Patients With Phenylketonuria (PKU) (NCT04085666) | Société des Produits Nestlé (SPN) | 2019-06-01 |
| Test of a New Gel-based Colon Cleansing Agent Compared to Moviprep (NCT03904303) | Zealand University Hospital | 2019-06-01 |
| Analgesics in the Pre-hospital Setting: Implications on Hemorrhage Tolerance - Fentanyl (NCT04136548) | University of Texas Southwestern Medical Center | 2019-06-01 |
| Study of Autologous CIK Cell Immunotherapy Combination With PD-1 Inhibitor and Chemotherapy in the Advanced NSCLC (NCT03987867) | Tianjin Medical University Cancer Institute and Hospital | 2019-06-01 |
| Evaluation of the Use of Photobiomodulation After the Installation of Elastometric Separators (NCT03939988) | University of Nove de Julho | 2019-06-01 |
| Acceptability and Feasibility of Unsupervised HIV Self-Testing Among Networks of Men (NCT03891407) | University of South Carolina | 2019-06-01 |
| Rapid Determination Of The Clinical Utility Of Perampanel For The Treatment Of Alcohol Dependence (NCT02120365) | Virginia Commonwealth University | 2019-06-01 |
| Comparison of Distraction Methods for Pain Relief of Trigger Finger Injection (NCT03445780) | NYU Langone Health | 2019-06-01 |
| Idelalisib With Rituximab, Ifosfamide, Carboplatin, Etoposide (RICE) in Children and Adolescents (NCT03349346) | Gilead Sciences | 2019-06-01 |
| A Study of the Safety and Pharmacokinetics of BRCX014 in Patients With Glioblastoma (NCT03687034) | Leaf Vertical Inc. | 2019-06-01 |
| The Effects of Sedatives on Tobacco Use Disorder (NCT03813121) | Wake Forest University Health Sciences | 2019-06-01 |
| High Dose Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic Cancer (NCT03697239) | Hitendra Patel | 2019-06-01 |
| Antimicrobial Synthetic Bone Grafts (NCT03945864) | Eskisehir Osmangazi University | 2019-06-01 |
| Stem Cell Therapy and Growth Factor Ovarian in Vitro Activation (NCT04009473) | Forever Young d.o.o. | 2019-06-01 |
| Therapeutic Potential of Stem Cell Conditioned Medium on Chronic Ulcer Wounds (NCT04134676) | Sukma Skin Treatment | 2019-06-01 |
| Fecal Microbiota Transplantation After Autologous HSCT in Patients With Multiple Sclerosis (NCT04203017) | St. Petersburg State Pavlov Medical University | 2019-06-01 |
| CD19+Targeted CAR-T Cell Therapy for Relapsed/Refractory CD19+ B Cell Leukemia and Lymphoma (NCT04271410) | Chongqing Precision Biotech Co., Ltd | 2019-06-01 |
| NPC-12G Gel 0.2% Sirolimus PK Bridging Study (NCT03972462) | Nobelpharma | 2019-05-31 |
| Safety and Efficacy of L19TNF in Patients With Isocitrate Dehydrogenase (IDH) Wildtype WHO Grade III / IV Glioma at First Relapse (NCT03779230) | Philogen S.p.A. | 2019-05-31 |
| To Compare the Pharmacokinetics and Safety of CT-P17 and Humira in Healthy Subjects (NCT03970824) | Celltrion | 2019-05-31 |
| ARRx in Combination With Enzalutamide in Metastatic Castration Resistant Prostate Cancer (NCT03300505) | University of Michigan Rogel Cancer Center | 2019-05-31 |
| A Study Comparing Immunopheresis® Alone or In Combination With Chemotherapy Versus Chemotherapy Alone in Treatment of Advanced Breast Cancer Patients (NCT04004910) | Immunicom Inc | 2019-05-31 |
| A Maximum Use Trial of Ruxolitinib Cream in Adolescent and Adult Participants With Atopic Dermatitis (NCT03920852) | Incyte Corporation | 2019-05-30 |
| A Clinical Trial of CK0801 (a New Drug) in Patients With Bone Marrow Failure Syndrome (BMF) (NCT03773393) | Cellenkos, Inc. | 2019-05-30 |
| A Study of KN046 in Subjects With Locally Advanced or Metastatic Triple-negative Breast Cancer (NCT03872791) | Jiangsu Alphamab Biopharmaceuticals Co., Ltd | 2019-05-30 |
| Safety and Efficacy of ABI-009 (Nab-rapamycin) in Combination With Pomalidomide and Dexamethasone for Relapsed and Refractory Multiple Myeloma (NCT03657420) | Massachusetts General Hospital | 2019-05-30 |
| Text Messaging-Based Smoking Cessation Program for Homeless Youth (NCT03874585) | RAND | 2019-05-30 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BIIB100 Administered Orally to Adults With Amyotrophic Lateral Sclerosis (NCT03945279) | Biogen | 2019-05-30 |
| Drug Concentration of Metformin According to Sampling Method (NCT03970434) | Chonbuk National University Hospital | 2019-05-30 |
| Study of ET140202 T Cells in Adults With Advanced Hepatocellular Carcinoma (NCT03998033) | Eureka Therapeutics Inc. | 2019-05-30 |
| Lentiviral Vector Gene Therapy - The Guard1 Trial of AVR-RD-02 for Subjects With Type 1 Gaucher Disease (NCT04145037) | AVROBIO | 2019-05-30 |
| AKT Inhibitor, Ipatasertib, With Endocrine and CDK 4/6 Inhibitor for Patients With Metastatic Breast Cancer (TAKTIC) (NCT03959891) | Massachusetts General Hospital | 2019-05-30 |
| A Single-center Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of LCAR-L10D Cell Formulations Targeting CD19 and CD22 in Patients With CD19- and/or CD22-Positive Relapsed/Refractory B-cell Lymphoma (NCT03593109) | Second Affiliated Hospital of Xi'an Jiaotong University | 2019-05-30 |
| A Phase I Study of QL1604 in Subjects With Advanced Solid Tumors (NCT05649761) | Qilu Pharmaceutical Co., Ltd. | 2019-05-29 |
| HF2 Therapy in the Treatment of Active Ulcerative Colitis (NCT03720002) | Sheba Medical Center | 2019-05-29 |
| Evaluation of a Combination of a Plant Extract and a Probiotic on Glucidic Metabolism in Women With PCOS and High Insulin Levels (NCT04029805) | Biosearch S.A. | 2019-05-29 |
| A Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors (NCT03849469) | Xencor, Inc. | 2019-05-29 |
| A Four-way Crossover Study of 3 Formulations of M207 With Intranasal Zolmitriptan in Healthy Volunteers (NCT03978403) | Zosano Pharma Corporation | 2019-05-29 |
| Study to Investigate the Absorption, Metabolism, and Excretion of [14C]-Pamiparib in Participants With Advanced Cancer (NCT03991494) | BeiGene | 2019-05-29 |
| Abemaciclib + Nivolumab in Patients With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma That Progressed or Recurred Within Six Months After Platinum-based Chemotherapy (NCT03655444) | Washington University School of Medicine | 2019-05-29 |
| FIH Ph 1 Study of TRPC5 Channel Inhibitor GFB-887 in Healthy Subjects (NCT03970122) | Goldfinch Bio, Inc. | 2019-05-29 |
| Ramucirumab + Pembrolizumab in Patients With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (NCT03650764) | Washington University School of Medicine | 2019-05-29 |
| Pharmacokinetics and Safety in Healthy Volunteers (NCT03917628) | Sinocelltech Ltd. | 2019-05-29 |
| INCB039110 in Combination With Dabrafenib and Trametinib in Patients With BRAF-mutant Melanoma and Other Solid Tumors. (NCT03272464) | Massachusetts General Hospital | 2019-05-29 |
| Abexinostat and Ibrutinib in Diffuse Large B-cell Lymphoma and Mantle Cell Lymphoma (NCT03939182) | Memorial Sloan Kettering Cancer Center | 2019-05-29 |
| Study to Investigate the Effect of Rifampin and Itraconazole on the Action of Pamiparib in Participants With Cancer (NCT03994211) | BeiGene | 2019-05-29 |
| DPI-Tobra-Kind Cyclops® in Children With Cystic Fibrosis (NCT03485456) | University Medical Center Groningen | 2019-05-29 |
| Ruxolitinib and Chemotherapy in Adolescents and Young Adults With Ph-like Acute Lymphoblastic Leukemia (NCT03571321) | University of Chicago | 2019-05-28 |
| Open Label Study of mRNA-3704 in Patients With Isolated Methylmalonic Acidemia (NCT03810690) | ModernaTX, Inc. | 2019-05-28 |
| A Study of Orally Administered Pimodivir in Adult Participants With Hepatic Impairment (NCT03816631) | Janssen-Cilag International NV | 2019-05-28 |
| B002 in Patients With HER2-positive Breast Cancer (NCT04382352) | Shanghai Pharmaceuticals Holding Co., Ltd | 2019-05-28 |
| Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Vadadustat in Hemodialysis Subjects With Anemia Associated With Chronic Kidney Disease (NCT03992066) | Akebia Therapeutics | 2019-05-28 |
| A Clinical Study to Investigate Safety, Tolerability and Distribution of CHF 6333 After One or After Repeated Inhalation in Patients With Cystic Fibrosis (CF) and in Patients With Non Cystic Fibrosis (NCFB) Bronchiectasis (NCT04010799) | Chiesi Farmaceutici S.p.A. | 2019-05-27 |
| Clinical Study to Evaluate OrienX010 in Combination With Toripalimab as Neoadjuvant Treatment in Advanced Melanoma (NCT04197882) | Peking University Cancer Hospital & Institute | 2019-05-27 |
| A Study of CD147-targeted CAR-T by Hepatic Artery Infusions for Very Advanced Hepatocellular Carcinoma (NCT03993743) | Xijing Hospital | 2019-05-27 |
| TAHP for Patients With HER2-positive Early Breast Cancer and Subsequent AHP Adjuvant tHerapy After Surgery (NCT03881878) | Samsung Medical Center | 2019-05-27 |
| APG-2449 in Patients With Advanced Solid Tumors (NCT03917043) | Ascentage Pharma Group Inc. | 2019-05-27 |
| Clinical Trial to Assess Pharmacokinetic Parameters and Safety of NNG-TMAB (Trastuzumab) on Recurrent or Metastatic Breast Cancer Patients. (NCT05301530) | Nanogen Pharmaceutical Biotechnology Joint Stock Company | 2019-05-27 |
| Humanized CD19 Chimeric Antigen Receptor (CAR)-Modified T Cell Therapy in Treating Patients With B-cell Malignancies (NCT04008251) | Wuhan Sian Medical Technology Co., Ltd | 2019-05-27 |
| Evaluate the Safety and Explore Efficacy of Umbilical Cord Mesenchymal Stem Cells in Acute Myocardial Infarction (NCT04056819) | Ever Supreme Bio Technology Co., Ltd. | 2019-05-27 |
| Effect of Charcoal on Gastrointestinal Absorption of Tiotropium (NCT03945344) | Orion Corporation, Orion Pharma | 2019-05-27 |
| Fibroblast Growth Factor (FGFs) / Fibroblast Growth Factor Receptor (FGFRs) Genetic as a Second-line Therapy for Recurrent / Progressive Gastric Cancer With INCB054828 and Paclitaxel a Study to Evaluate the Safety and Efficacy of Combination Therapy. (NCT05529667) | Yonsei University | 2019-05-27 |
| Pilot Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Abuse Liability of an Abuse-Deterrent Immediate-Release Formulation (ADAIR) (NCT04232644) | Vallon Pharmaceuticals, Inc. | 2019-05-27 |
| Study of Alofanib in Patients With Metastatic Gastric Cancer (NCT04071184) | Russian Pharmaceutical Technologies | 2019-05-26 |
| Pharmacokinetic Study of Vancomycin, Clindamycin And/or Gentamicin Administration During Surgery Using a Microdialysis Procedure (NCT03845790) | Poitiers University Hospital | 2019-05-26 |
| Metabolism and Disposition of [14C] Herombopag in Chinese Healthy Human Subjects (NCT03977805) | Jiangsu HengRui Medicine Co., Ltd. | 2019-05-25 |
| ORIN1001 in Patients with Advanced Solid Tumors and Relapsed Refractory Metastatic Breast Cancer (NCT03950570) | Orinove, Inc. | 2019-05-25 |
| Combination of GT90001 and Nivolumab in Patients With Metastatic Hepatocellular Carcinoma(HCC) (NCT03893695) | Suzhou Kintor Pharmaceutical Inc, | 2019-05-25 |
| Pracinostat and Gemtuzumab Ozogamicin (PraGO) in Patients With Relapsed/Refractory Acute Myeloid Leukemia (NCT03848754) | Medical College of Wisconsin | 2019-05-24 |
| The Erector Spinae Plane Block and Its Effect on Respiratory Status and Pain Management in Rib Fracture Patients (NCT03805360) | Virginia Commonwealth University | 2019-05-24 |
| A Study of AG-636 in the Treatment of Subjects With Advanced Lymphoma (NCT03834584) | Agios Pharmaceuticals, Inc. | 2019-05-24 |
| Evaluation of a Probiotic on LDL-cholesterol Levels (NCT04029818) | Biosearch S.A. | 2019-05-24 |
| A Study of LY3434172, a PD-1 and PD-L1 Bispecific Antibody, in Advanced Cancer (NCT03936959) | Eli Lilly and Company | 2019-05-24 |
| Prazosin Use in Adults With Anxiety Disorders (NCT03894345) | University of Manitoba | 2019-05-24 |
| Talimogene Laherparepvec for the Treatment of Peritoneal Surface Malignancies (NCT03663712) | Dan Blazer III, M.D. | 2019-05-23 |
| Sanaria PfSPZ Challenge With Pyrimethamine or Chloroquine Chemoprophylaxis Vaccination (PfSPZ-CVac Approach): A Randomized Double Blind Placebo Controlled Phase I/II Trial to Determine Safety and Protective Efficacy Against Natural Plasmodium Falcipa... (NCT03952650) | National Institute of Allergy and Infectious Diseases (NIAID) | 2019-05-23 |
| Study of Recombinant Human Anti-PD-1 Monoclonal Antibody in Patients With Advanced Tumours (NCT03852823) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2019-05-23 |
| Open-Label Study of Long-Term Safety and Efficacy of Intravenous Trappsol Cyclo (HPβCD) in Niemann-Pick Disease Type C (NCT03893071) | Cyclo Therapeutics, Inc. | 2019-05-23 |
| A Clinical Trial in Healthy, HIV-1-Uninfected Adult Participants to Compare the Safety, Tolerability and Immunogenicity of CH505TF gp120 Produced From Stably Transfected Cells to CH505TF gp120 Produced From Transiently Transfected Cells (NCT03856996) | National Institute of Allergy and Infectious Diseases (NIAID) | 2019-05-23 |
| Trial of Mosunetuzumab (BTCT4465A) as Consolidation Therapy in Participants With Diffuse Large B-Cell Lymphoma Following First-Line Immunochemotherapy and as Monotherapy or in Combination With Polatuzumab Vedotin in Elderly/Unfit Participants With Previously Untreated Diffuse Large B-Cell Lymphoma (NCT03677154) | Hoffmann-La Roche | 2019-05-23 |
| Study Evaluating the Effect of ETX2514 on Cardiac Repolarization in Healthy Male or Female Volunteers (NCT03985410) | Entasis Therapeutics | 2019-05-23 |
| A Study to Evaluate the Safety, Tolerability and Efficacy of Multiple Doses of JS002 in Patients With Hyperlipidemia.. (NCT04469673) | Shanghai Junshi Bioscience Co., Ltd. | 2019-05-23 |
| Study to Evaluate the Safety and Preliminary Efficacy of IDCT, a Treatment for Symptomatic Lumbar Disc Degeneration (NCT03955315) | DiscGenics, Inc. | 2019-05-23 |
| Sub-Lingual Dexmedetomidine in Agitation Associated With Schizophrenia (NCT04010305) | BioXcel Therapeutics Inc | 2019-05-22 |
| Phase Ib/II Trial of Nal-Irinotecan and Nivolumab as Second-Line Treatment in Patients With Advanced Biliary Tract Cancer (NCT03785873) | University of Michigan Rogel Cancer Center | 2019-05-22 |
| Busulfan, Melphalan, Escalating Carfilzomib Conditioning Auto Stem Cell Transplantation for Multiple Myeloma (MM) (NCT03795597) | Loyola University | 2019-05-22 |
| A Drug Interaction Study of KW-6356 With Midazolam, Caffeine, or Rosuvastatin (NCT03970798) | Kyowa Kirin Co., Ltd. | 2019-05-22 |
| Gevokizumab With Standard of Care Anti-cancer Therapies for Metastatic Colorectal, Gastroesophageal, and Renal Cancers (NCT03798626) | Novartis Pharmaceuticals | 2019-05-22 |
| Induction Paclitaxel Followed by Concurrent Paclitaxel and Radiation Therapy for Cutaneous Angiosarcoma (NCT03921008) | Washington University School of Medicine | 2019-05-21 |
| Human Bioequivalence Test of Liraglutide Injection (NCT05029076) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2019-05-21 |
| A Study of LY3361237 in Participants With Systemic Lupus Erythematosus (NCT03933943) | Eli Lilly and Company | 2019-05-21 |
| A Study to Assess Pharmacokinetics of PF-04965842 and Its Metabolites and Effect of Probenecid in Healthy Participants (NCT03937258) | Pfizer | 2019-05-21 |